Public trial registry of the CCC-Munich

Trial Keylynk // MK7339-001

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
Keylynk // MK7339-001
World
Full title
:

A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA non-mutated Advanced Epithelial Ovarian Cancer (EOC)

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Gynecological tumor
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Chemo,Zielgerichtet - Therapieart: adjuvant

Participants
Function Prename Surname Organization
World Responsible contact Marion Kiechle Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Magnifier